期刊文献+

IL-18基因rs1946518位点多态性及血清IL-18水平与宫颈癌的关系 被引量:1

The rs1946518 Polymorphisms and Concentration of IL-18 Concern the Risk of Cervical Cancer
下载PDF
导出
摘要 目的:研究白介素-18(IL-18)基因rs1946518多态性位点以及相应血清IL-18含量与宫颈癌的关系。方法:选择50例宫颈癌患者和50例健康对照为研究对象,采集外周静脉血,用直接测序法对IL-18基因启动子区rs1946518单核苷酸多态性(SNP)位点进行检测,并用双抗体夹心酶联免疫吸附试验(ELISA)检测血清中IL-18含量。结果:rs1946518SNP位点以3种基因型存在,即A/A、C/C、A/C;患者组3种基因型频率分别为56%(28/50)、10%(5/50)和34%(17/50),对照组3种基因型频率分别为18%(9/50)、34%(17/50)和48%(17/50),2组间基因型的分布频率差异和等位基因A、C频率差异有统计学意义。采用析因设计方差分析显示2组间血清IL-18平均浓度差异有统计学意义;按照上述3个基因型分为3组,3组的血清IL-18平均浓度差异有统计学意义;宫颈癌患病与否与不同IL-18基因型之间交互效应显著。结论:IL-18基因启动子rs1946518位点多态性及相应血清IL-18含量都与宫颈癌相关,rs1946518位点多态性可能是控制宫颈癌发生发展的重要遗传因素。 Objective: To explore the role of the concentration of interleukin-18(IL-18) in serum and rs1946518 polymorphisms in the development of cervical cancer(CC). Methods: One single nucleotide polymorphisms(SNP) site of the promoter region of IL-18 gene at position rs1946518 was screened out and sequenced in 50 CC subjects and 50 control subjects that matched to the CC cases in age and residence. The concentration of IL-18 in serum was tested with IL-18 ELISA reagent kit. Results: rs1946518 existed by three kinds of genotype as A/A, C/C and A/C. A significant difference of the three genotype frequency was observed between patients and controls. The frequency of A allele was 42%(42/100) in normal controls and 73%(73/100) in patients, showing significant diference. Factorial ANOVA was used to analyze the relationship between the risk of CC and concentration of IL-18, and rs1946518 polymorphisms, respectively. The mean value of IL-18 concentrations in serum of CC group and in controls showed significant difference. The mean value of IL- 18 concentrations in serum of the A/A group, in the C/C group, and in the A/C group showed significant difference. A significant difference of the interaction effect was observed between the two fixed factors. Conclusion: IL-18 gene polymorphisms may result in pathogenesis by influencing IL-18 levels in serum, rs1946518 was proven to be involved in susceptibility for cervical neoplasm.
出处 《生物技术通讯》 CAS 2008年第3期377-379,共3页 Letters in Biotechnology
基金 卫生部科研基金项目(WKJ2007-3-001)
关键词 单核苷酸多态性 宫颈癌 白介素-18 rs1946518 single nucleotide polymorphisms cervical neoplasm interleukin-18 rs1946518
  • 相关文献

参考文献12

  • 1李芳芳,方红辉,冯志勇,甘志彪,何桂蓉.高危人乳头瘤病毒基因型与宫颈癌筛查[J].生物技术通讯,2005,16(6):651-652. 被引量:4
  • 2Lars-Christian H, Georgios R. Familial cancer history in patients with carcinoma of the cervix uteri[J]. Eur J Obstet Gynecol Reprod Biol, 2002,101:54-57.
  • 3Zhang B, Wu K F, Cao Z Y, et al. IL-18 increases invasiveness of HL-60 myeloid leukemia cells:up-regpμlation of matrix metalloproteinases-9(MMP-9) expression[J]. Leuk Res, 2004,28(1):91-95.
  • 4Micallef M J, Yoshida K, Kawai S, et al. In vivo antitumor efects of murine interferon-r-inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites[J]. Cancer Immunol Immunother, 1997,43(6):361-367.
  • 5Okamura H, Tsutsi H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells [J]. Nature, 1995,378:88-91.
  • 6Nakamura K, Okamura H, Wada M, et al. Endotoxin-induced serum factor that stimulates gamma interferon production[J]. Infect Immun, 1989,57:590-595.
  • 7Ghayur T, Banerjee S, Hugunin M, et al. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production[J]. Nature, 1997,386:619-623.
  • 8Lee S J, Cho Y S, Cho M C, et al. Both E6 and E7 oncoproteins of human papillomavirus 16 inhibit IL-18-induced IFN-gamma production in human peripheral blood mononuclear and NK cells[J]. J Immunol, 2001,167(1):497-504.
  • 9Lee K A, Cho K J, Kim S H, et al. IL-18 E42A mutant is resistant to the inhibitory effects of HPV-16 E6 and E7 oncogenes on the IL-18-mediated immune response[J]. Cancer Lett, 2005,229(2): 261-270.
  • 10Cho Y S, Kang J W, Cho M, et al. Down modμlation of IL-18 expression by human papillomavirus type 16 E6 oncogene via binding to IL-18[J]. FEBS Lett, 2001,501:139-145.

二级参考文献8

  • 1李洁,刘宝印,zur Hausen H,王宏,杨学志,李力,刘文,刘洪隐,陆克昭,刘旭,牛春燕,裴润芳,苏钟浦,王言贵,董继华,张桂宁,刘春杰,许吉林,林毓纯.中国妇女宫颈癌组织中人乳头瘤病毒感染及其地理分布的调查[J].中华实验和临床病毒学杂志,1996,10(1):50-55. 被引量:67
  • 2Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: GLOBOCAN 2000[J]. Int J Cancer, 2001,94:153
  • 3Zhang WH, Coppleson M, Rose BR, et al. Papillomavirus and cervical cancer: A clinical and laboratory study[J]. J Med Virol, 1988,26:163
  • 4Mclachlin CM. Human papillomavirus in cervical neoplasia. Role,risk factors, and implications[J]. Clin Lab Med, 2000,20(2):257
  • 5Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a world perspective[J]. J National Cancer Inst, 1995,87:796
  • 6Walboomers JM, Jaclbs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide[J]. J Pathol, 1999,189:12
  • 7Schiffman MH, Herero R, Hildesheim A, et al. HPV DNA testing in cervivcal cancer screening[J]. JAMA, 2002,283:87
  • 8Hopman EH, Rozendaal L, Voorhorst FJ, et al. High risk human papillomavirus in woman with normal cervical cyotolgy prior to the development of abnormal.cytology and colposcopy[J]. Bri J Obstetrics Gynaecol, 2000,107:600

共引文献3

同被引文献10

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部